Potentiation of anticancer activity of capecitabine is required to improve its therapeutic index. In colorectal cancer (CRC) cells, we evaluated whether the histone deacetylase-inhibitor ...

It ensures any stray cancer cells left after surgery don’t continue to grow. Second, capecitabine can be used ... at some of the most common. First-line chemotherapy for gallbladder cancer ...

The oral fluoropyrimidine capecitabine is an established alternative to bolus fluorouracil plus leucovorin as first-line treatment for ... including tumor cells in ascites or microscopic evidence ...

The body changes capecitabine into a common chemotherapy drug called fluorouracil. It stops cells from making and repairing DNA ... You should contact your advice line urgently if you think you have ...

Take capecitabine tablets morning and evening. You have blood tests before and during your treatment. They check your levels of blood cells and other substances ... You should contact your advice line ...

We evaluated capecitabine (an oral fluoropyrimidine ... if they had a histologically proven adenocarcinoma, squamous-cell carcinoma, or undifferentiated carcinoma of the esophagus ...

Focus V has shown limited PFS benefit, a high incidence of AEs, and no demonstrated improvement in overall survival.

CYT-0851 demonstrated activity in combination with capecitabine in heavily pretreated ... Inhibiting MCT function in glycolytic cancer cells leads to an accumulation of intracellular lactate ...

Because there was likely to have been considerable overlap between these 2 groups (and perhaps total overlap, as assumed by the manufacturer), a significant percentage of patients (up to 37%) could ...